Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Sucampo Pharma Inc (SCMP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 450,662
  • Shares Outstanding, K 46,460
  • Annual Sales, $ 230,060 K
  • Annual Income, $ 18,490 K
  • 36-Month Beta 1.41
  • Price/Sales 1.95
  • Price/Cash Flow 4.00
  • Price/Book 2.68

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.30 +4.30%
on 04/18/17
11.30 -14.16%
on 03/29/17
-0.90 (-8.49%)
since 03/24/17
3-Month
9.30 +4.30%
on 04/18/17
12.75 -23.92%
on 03/08/17
-1.25 (-11.42%)
since 01/25/17
52-Week
9.30 +4.30%
on 04/18/17
17.55 -44.73%
on 11/30/16
-1.53 (-13.62%)
since 04/25/16

Most Recent Stories

More News
Sucampo Pharmaceuticals Shares Down 30.8% Since SmarTrend's Sell Call (SCMP)

SmarTrend identified a Downtrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on December 20th, 2016 at $13.87. In approximately 4 months, Sucampo Pharmaceuticals has returned 30.79% as of today's recent...

SCMP : 9.70 (+0.52%)
Sucampo Announces First Quarter 2017 Earnings Call

Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its first quarter 2017 financial results teleconference and webcast at 8:30...

SCMP : 9.70 (+0.52%)
New Study Published in PLOS ONE Advances Science Around VTS-270 for Treatment of Niemann-Pick Disease Type C1

Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced the publication of a new study in an independent scientific journal that confirms the unique composition...

SCMP : 9.70 (+0.52%)
Shares of SCMP Down 29.2% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on December 20th, 2016 at $13.87. In approximately 4 months, Sucampo Pharmaceuticals has returned 29.16% as of today's recent...

SCMP : 9.70 (+0.52%)
Sucampo (SCMP) Down 7.6% Since Earnings Report: Can It Rebound?

Sucampo (SCMP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

SCMP : 9.70 (+0.52%)
Drug Makers Stocks Under Scanner -- Synergy Pharma, Novo Nordisk, Apricus Biosciences, and Sucampo Pharma

Stock-Callers.com has issued research reports on four Drug Manufacturers stocks, which are: Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), Novo Nordisk A/S (NYSE: NVO), Apricus Biosciences Inc. (NASDAQ:...

SCMP : 9.70 (+0.52%)
NVO : 37.08 (+1.48%)
APRI : 1.16 (-4.92%)
SGYP : 4.21 (+2.43%)
Sucampo Pharmaceuticals Has Returned 24.3% Since SmarTrend Recommendation (SCMP)

SmarTrend identified a Downtrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on December 20th, 2016 at $13.87. In approximately 4 months, Sucampo Pharmaceuticals has returned 24.30% as of today's recent...

SCMP : 9.70 (+0.52%)
Cydan Development Announces the Acquisition of Its First Rare Disease Spin-out, Vtesse, Inc. by Sucampo Pharmaceuticals, Inc.

Cydan Development, Inc., an orphan drug accelerator dedicated to creating therapies that improve the lives of people living with rare genetic diseases, today announces that Vtesse,...

SCMP : 9.70 (+0.52%)
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Oppenheimer 27th Annual Healthcare Conference

Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate presentation at the Oppenheimer 27 Annual Healthcare Conference....

SCMP : 9.70 (+0.52%)
Sucampo Pharmaceuticals (SCMP): Moving Average Crossover Alert

Sucampo Pharmaceuticals, Inc. (SCMP) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front

SCMP : 9.70 (+0.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

Sucampo Pharmaceuticals, Inc. is an emerging pharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. Sucampo is focused on developing prostones...

See More

Support & Resistance

2nd Resistance Point 10.07
1st Resistance Point 9.88
Last Price 9.70
1st Support Level 9.58
2nd Support Level 9.47

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.